Venturini, M <br/><br/>
An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.  [electronic resource] 

 -  Oncology  2007 
 - 51-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000111094  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Capecitabine<br/>Deoxycytidine--adverse effects<br/>Disease Progression<br/>Female<br/>Fluorouracil--adverse effects<br/>Humans<br/>Middle Aged<br/>Survival Analysis<br/>Treatment Outcome